Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Andrea Napolitano"'
Autor:
Sebastian Bauer, Margherita Nannini, Marta Sbaraglia, Mariella Spalato Ceruso, Nadia Hindi, Heikki Joensuu, Peter Reichardt, Antoine Italiano, Angelo Paolo Dei Tos, Jean-Yves Blay, Silvia Gasperoni, Marianna Silletta, Maria Abbondanza Pantaleo, Winan J. van Houdt, Giuseppe Tonini, Piotr Rutkowski, Robin L. Jones, Giovanni Grignani, Spyridon Gennatas, Giuseppe Badalamenti, Hans Gelderblom, Peter Hohenberger, Nikki S. IJzerman, Neeltje Steeghs, Javier Martin-Broto, Tommaso De Pas, Axel Le Cesne, Marta Fiocco, Ingrid M.E. Desar, Paolo G. Casali, Antonella Brunello, Andrea Napolitano, Johanna Falkenhorst, Bruno Vincenzi, Alessandro Gronchi, Elena Fumagalli, Olivier Mir
Publikováno v:
Clinical Cancer Research, 28(8), 1672-1679. AMER ASSOC CANCER RESEARCH
Clinical Cancer Research, 28(8), 1672-1679. American Association for Cancer Research Inc.
Clinical Cancer Research, 28, 1672-1679
Clinical Cancer Research, 28, 8, pp. 1672-1679
Clinical Cancer Research, 28(8), 1672-1679. American Association for Cancer Research Inc.
Clinical Cancer Research, 28, 1672-1679
Clinical Cancer Research, 28, 8, pp. 1672-1679
[Purpose] The effect of high-dose imatinib (800 mg/day) on survival in the adjuvant treatment of patients with resected KIT exon 9–mutated gastrointestinal stromal tumors (GIST) is not established. Here, the association of dose and other clinicopat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be9a2221f308b987c6286dcc109c6f6d
https://www.ncbi.nlm.nih.gov/pubmed/34615721
https://www.ncbi.nlm.nih.gov/pubmed/34615721
Autor:
G. Tonini, Daria Maggi, Gaia Tabacco, Andrea Palermo, Daniele Santini, Anna Crescenzi, Chiara Taffon, Anda Mihaela Naciu, Andrea Napolitano, Francesco Pantano, Silvia Manfrini, Bruno Vincenzi
Publikováno v:
Eur Thyroid J
Immune checkpoint inhibitors have been recently approved for cancer treatment. Nivolumab is a monoclonal antibody specific for programmed cell death-1 (PD-1) that modulates T-cell response. It was initially used for the treatment of malignant melanom
Publikováno v:
Cells, Vol 10, Iss 1533, p 1533 (2021)
Cells
Cells
Sarcomas are a heterogeneous group of rare malignancies originating from mesenchymal tissues with limited therapeutic options. Recently, alterations in components of the fibroblast growth factor receptor (FGFR) signaling pathway have been identified
Autor:
Francesca Vignani, Elena Verzoni, Mariella Sorarù, Francesco Grillone, Giandomenico Roviello, Rocco De Vivo, Giuseppe Di Lorenzo, Emanuele Naglieri, Sebastiano Buti, Marilena Di Napoli, Andrea Sbrana, Marco Stellato, Marco Maruzzo, Giuseppe Procopio, Daniele Santini, Ugo De Giorgi, Francesco Pantano, Andrea Napolitano, Giuseppe Fornarini, Claudia Mucciarini, Chiara Casadei
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
BackgroundImmune-Oncology (IO) improves Overall Survival (OS) in metastatic Renal Cell Carcinoma (mRCC). The prognostic impact of previous Cytoreductive Nephrectomy (CN) and radical nephrectomy (RN), with curative intent, in patients treated with IO
Autor:
Bruno Beomonte Zobel, Daniele Santini, Marco Russano, Bruno Vincenzi, Yipeng Sun, Andrea Napolitano, Carlo Cosimo Quattrocchi, Gennaro Castiello, Carlo Augusto Mallio, Mario Iozzino, Silvia Angeletti, Francesco Maria Giordano, Giuseppe Tonini, Pasquale D'Alessio
Publikováno v:
Cancers, Vol 13, Iss 652, p 652 (2021)
Cancers
Volume 13
Issue 4
Cancers
Volume 13
Issue 4
Background: Coronavirus disease 2019 (COVID-19) pneumonia and immune checkpoint inhibitor (ICI) therapy-related pneumonitis share common features. The aim of this study was to determine on chest computed tomography (CT) images whether a deep convolut
Autor:
Daniele Santini, Bruno Vincenzi, Antonio Russo, Giuseppe Tonini, Andrea Napolitano, Angelo Onorato, Silvia Spoto, Lorena Incorvaia
Publikováno v:
Chemotherapy. 66(5-6)
Background: Fatigue is a common distressing symptom for patients living with chronic or acute diseases, including liver disorders and cancer (Cancer-Related Fatigue, CRF). Its etiology is multifactorial, and some hypotheses regarding the pathogenesis
Autor:
Francesca Baldo, Alessandro Minelli, Mariella Spalato Ceruso, Marianna Silletta, Daniele Santini, Alessandro Mazzocca, Giuseppe Badalamenti, Bruno Vincenzi, Giuseppe Tonini, Andrea Napolitano, Lorena Incorvaia
Publikováno v:
Cancers
Cancers, Vol 12, Iss 2135, p 2135 (2020)
Cancers, Vol 12, Iss 2135, p 2135 (2020)
The desmoid tumor is a locally aggressive proliferative disease within the family of soft-tissue sarcomas. Despite its relatively good prognosis, the clinical management of desmoid tumors requires constant multidisciplinary evaluation due to its high
Autor:
Andrea Napolitano, Emanuela Dell'Aquila, Francesco Pantano, Giuseppe Tonini, Fabrizio Citarella, Daniele Santini, Bruno Vincenzi, Alessio Cortellini, Marco Russano
Publikováno v:
Expert Opinion on Biological Therapy
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Introduction The COVID-19 pandemic occurred amid the cancer immunotherapy revolution. Immune checkpoint inhibitors (ICIs) have become the standard of care for several solid cancers and are associated with peculiar toxicities, including pneumonitis wh
Autor:
Cecilia Anesi, Antonella Argentiero, Nicola Silvestris, Bruno Vincenzi, Daniele Santini, Giulia Ribelli, Emanuela Dell'Aquila, Michele Iuliani, Sonia Simonetti, Andrea Napolitano, Fabrizio Citarella, Francesco Pantano, Giuseppe Tonini, Marco Russano, Antonio Giovanni Solimando
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-1 (2020)
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research : CR
In a large number of cancer types, treatment selection depends on the presence of specific tumor biomarkers. Due to the dynamic nature of cancer, very often these predictive biomarkers are not uniformly present in all cancer cells. Tumor heterogeneit
Autor:
Francesco Pantano, Bruno Vincenzi, Sonia Simonetti, Michele Iuliani, Giuseppe Tonini, Giulia Ribelli, Andrea Napolitano, Daniele Santini
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, Vol 10 (2020)
Bone is one of the preferential sites of distant metastases from malignant tumors, with the highest prevalence observed in breast and prostate cancers. Patients with bone metastases (BMs) may experience skeletal-related events, such as severe bone pa